{
  "_description": "Example response shape for GET https://api.fda.gov/drug/event.json?search=patient.drug.openfda.brand_name:lipitor&limit=1 — illustrates the common meta envelope plus a single (abbreviated) FAERS adverse event record.",
  "_request": "GET https://api.fda.gov/drug/event.json?search=patient.drug.openfda.brand_name:lipitor&limit=1",
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://creativecommons.org/publicdomain/zero/1.0/",
    "last_updated": "2026-05-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 412938
    }
  },
  "results": [
    {
      "safetyreportid": "EXAMPLE-12345678",
      "receiptdate": "20240115",
      "receivedate": "20240115",
      "serious": "1",
      "seriousnessother": "1",
      "occurcountry": "US",
      "primarysource": {
        "qualification": "1",
        "reportercountry": "US"
      },
      "patient": {
        "patientonsetage": "62",
        "patientonsetageunit": "801",
        "patientsex": "2",
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "LIPITOR",
            "drugindication": "HYPERLIPIDEMIA",
            "openfda": {
              "brand_name": ["LIPITOR"],
              "generic_name": ["ATORVASTATIN CALCIUM"],
              "product_ndc": ["0071-0155"],
              "manufacturer_name": ["Parke-Davis Div of Pfizer Inc"],
              "route": ["ORAL"],
              "substance_name": ["ATORVASTATIN CALCIUM"]
            }
          }
        ],
        "reaction": [
          {
            "reactionmeddrapt": "Myalgia",
            "reactionoutcome": "6"
          }
        ]
      }
    }
  ]
}